Advanced Enzyme Technologies Limited
₹262.95-₹1.45 (-0.5%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹3,248 Cr
- P/E
- 26.5x
- EV / EBITDA
- 22.1x
- Revenue
- ₹351 Cr
- Net margin
- 29.6%
- ROCE
- 18.0%
Price chart
Technical chartScreen technicals →-15.6% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -6.3%
- 3M
- -14.0%
- 6M
- -24.4%
- 1Y
- -15.6%
- 5Y
- -27.8%
52-week range
Day change -₹1.45 (-0.5%) from ₹264 to ₹263 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in ADVENZYMES, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Healthy return on equity of 18.6%
Concerns0
Rule-based from financial data. Not advice.
About the company
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally.
Read moreShow less
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.
- Sector
- Technology
- Shares outstanding
- 11.2 Cr shares
- ISIN
- INE837H01020
- BSE code
- 540025
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹3,248 Cr
- P/E
- 26.5x
- P/B
- 4.8x
- EV / EBITDA
- 22.1x
- EV / Sales
- 8.8x
- P/S
- 8.9x
- Earnings yield
- 3.8%
- 52-week high
- ₹391.35
- 52-week low
- ₹248.20
Profitability
- Operating margin
- 28.8%
- Net margin
- 29.6%
- EBITDA margin
- 39.7%
- ROE
- 18.6%
- ROCE
- 18.0%
- ROA
- 17.1%
- Dividend payout
- 53.0%
- Tax rate
- 19.0%
- Other income, % of PBT
- 29.9%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹351 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -3.8%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 8.1%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹145 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 70.6%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -5.6%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 13.2%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹52.0 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 4.0%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹4.00 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 9.9%
Solvency and efficiency
- Current ratio
- 9.20
- Debt / Equity
- 0.00
- Debt / Assets
- 0.00
- Debt / EBITDA
- 0.01
- Financial leverage
- 1.09
- CFO / Net profit
- 0.48
- Cash / Market cap
- 6.6%
- Cash per share
- ₹19.02
- Asset turnover
- 0.58
- Fixed asset turnover
- 2.57
- Capital intensity
- 0.39
- Debtor days
- 75 days
- Inventory turnover
- 1.36
- Cash conversion cycle
- 283 days
Where the revenue went
Some FY2025 lines are not reported, so the ones that are appear as a table.
| Line | FY2025 |
|---|---|
| Sales | ₹351 Cr |
| Expenses | ₹280 Cr |
| Operating profit | ₹71 Cr |
| Other income | ₹61 Cr |
| Interest | ₹1 Cr |
| Depreciation | ₹11 Cr |
| Profit before tax | ₹121 Cr |
| Tax and other | ₹19 Cr |
| Net profit | ₹102 Cr |
Revenue and net profit
Revenue fell 3.8% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹283 Cr | ₹71 Cr |
| FY2022 | ₹273 Cr | ₹55 Cr |
| FY2023 | ₹312 Cr | ₹56 Cr |
| FY2024 | ₹365 Cr | ₹108 Cr |
| FY2025 | ₹351 Cr | ₹102 Cr |
Cash flows
FY2025: ₹63.0 Cr from operations, ₹61.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹84 Cr | ₹14 Cr |
| FY2022 | ₹37 Cr | ₹23 Cr |
| FY2023 | ₹50 Cr | ₹8 Cr |
| FY2024 | ₹52 Cr | ₹49 Cr |
| FY2025 | ₹63 Cr | ₹61 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹351 Cr-3.8%1Y
- Net profit
- ₹102 Cr-5.6%1Y
- Cash from operations
- ₹63 Cr
- Free cash flow
- ₹61 Cr+24.5%1Y
- Revenue CAGR, 5Y
- 8.1%
- EBITDA CAGR, 5Y
- 11.0%
- Net profit CAGR, 5Y
- 13.2%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹351 Cr | ₹71 Cr | — | ₹102 Cr | ₹63 Cr | ₹61 Cr | 16.2% | -3.8% | -5.6% |
Monthly returns
Month-by-month returns of ADVENZYMES across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹689 Cr |
| Equity capital | ₹22 Cr |
| Reserves | ₹607 Cr |
| Borrowings | ₹3 Cr |
| Other liabilities | ₹57 Cr |
| Assets | ₹689 Cr |
| Fixed assets | ₹156 Cr |
| Capital work in progress | ₹21 Cr |
| Investments | ₹290 Cr |
| Other assets | ₹221 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
ADVENZYMES trades at 26.5x earnings against a peer median of 52.1x (a 49% discount).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Advanced Enzyme Technologies LimitedADVENZYMESthis companyP/E ↓ discount | ₹3,248 Cr | 26.5x | 4.8x | 18.6% | 22.1x |
| MOSCHIP TECHNOLOGIES LIMITEDMOSCHIP | ₹3,729 Cr | 95.8x | 10.2x | 2.2% | 163.7x |
| Shilchar Technologies Ltd.SHILCTECH | ₹3,663 Cr | 20.6x | 8.7x | 43.8% | 28.7x |
| Sandhar Technologies LimitedSANDHAR | ₹3,369 Cr | 19.2x | 2.7x | 10.9% | 13.3x |
| 63 Moons Technologies Limited63MOONS | ₹3,203 Cr | 83.9x | 1.1x | 9.4% | 10.1x |
| Cyient DLM LimitedCYIENTDLM | ₹3,173 Cr | 42.1x | 3.3x | 6.7% | 22.3x |
| ROSSARI BIOTECH LIMITEDROSSARI | ₹3,016 Cr | 25.0x | 2.7x | 10.4% | 17.7x |
| Protean eGov Technologies LimitedPROTEAN | ₹2,888 Cr | 30.5x | 2.8x | 10.8% | 17.5x |
| Network People Services Technologies LimitedNPST | ₹2,762 Cr | 97.8x | 6.6x | 47.4% | 59.8x |
| Peer median | — | 52.1x | 7.8x | 14.5% | 34.2x |
Year-to-date ROI
ADVENZYMES since 1 January, against earlier years.
Historical volatility
ADVENZYMES's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 36.0% |
| FY2022 | 27.0% |
| FY2023 | 24.0% |
| FY2024 | 29.0% |
| FY2025 | 20.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹351 Cr |
| Costs | |
| Interest | ₹1 Cr |
| Expenses | ₹280 Cr |
| Operating profitOperating Profit | ₹71 Cr |
| Other income and charges | |
| Profit before tax | ₹121 Cr |
| Tax | |
| Net profitNet Profit | ₹102 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹689 Cr |
| Equity capitalEquity Capital | ₹22 Cr |
| Reserves | ₹607 Cr |
| Borrowings | ₹3 Cr |
| Other liabilitiesOther Liabilities | ₹57 Cr |
| AssetsTotal Assets | ₹689 Cr |
| Fixed assetsFixed Assets | ₹156 Cr |
| Capital work in progressCWIP | ₹21 Cr |
| Investments | ₹290 Cr |
| Other assetsOther Assets | ₹221 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹63 Cr |
| Investing cash flowCash from Investing Activity | -₹2 Cr |
| Financing cash flowCash from Financing Activity | -₹58 Cr |
| Change in cashNet Cash Flow | ₹4 Cr |
Learn while you research
Academy chapters picked for Advanced Enzyme Technologies Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Growth InvestingTech & communications often trade on growth, learn the framework.7 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read